Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test, Vomiting
Clinical narrative: Dehydrated; Fatigue; Coughing; Excessive vomiting; Fever; Headache; Sore throat; Exteme nausea continued for 7 days; Missed two days of work; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Coughing), HEADACHE (Headache), VOMITING (Excessive vomiting), PYREXIA (Fever) and OROPHARYNGEAL PAIN (Sore throat) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002F21 and 003C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Acute symptoms lasted for 2.5 weeks and cough for a month) on 27-Mar-2020, Breathing difficult (Breathing issues : had follow up and testing) and Stomach upset (Long haul stomach : had follow up and testing). Concurrent medical conditions included High cholesterol, Heartburn (Reflux / heartburn), Altered smell sensation (patent was still smelling phantom smell) and Acid reflux (esophageal) (Reflux/heartburn). Concomitant products included OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) for Acid reflux (esophageal), SIMVASTATIN (ZOCOR) for Cholesterol.   On 23-Jul-2021 at 4:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Aug-2021 at 2:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In August 2021, the patient experienced IMPAIRED WORK ABILITY (Missed two days of work) and NAUSEA (Exteme nausea continued for 7 days). On 18-Aug-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat). On 18-Aug-2021 at 3:30 PM, the patient experienced HEADACHE (Headache) and PYREXIA (Fever). On 18-Aug-2021 at 8:00 PM, the patient experienced COUGH (Coughing) and VOMITING (Excessive vomiting). On an unknown date, the patient experienced DEHYDRATION (Dehydrated) and FATIGUE (Fatigue). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) in August 2021 for Adverse event, at an unspecified dose and frequency. In August 2021, IMPAIRED WORK ABILITY (Missed two days of work) and NAUSEA (Exteme nausea continued for 7 days) had resolved. On 19-Aug-2021 at 8:00 AM, VOMITING (Excessive vomiting) had resolved. At the time of the report, COUGH (Coughing), HEADACHE (Headache) and PYREXIA (Fever) had resolved and OROPHARYNGEAL PAIN (Sore throat), DEHYDRATION (Dehydrated) and FATIGUE (Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Mar-2020, SARS-CoV-2 test: positive (Positive) Tested Positive.         The treatment with Zofran did not help the patient. The patient had no allergic reaction to food, medication or other products and had no acute illness at time of vaccination and till prior to one month.  The patient had COVID-19 at the beginning of lockdown. Follow up and testing with the pulmonologist, gastroenterologists for 6 months was done. The patient was still smelling phantoms but was otherwise fine.   The patient woke up around 3 A.M and started vomiting again for at least 6-8 times. The patient felt going to emergency room as due to dehydration but was not able to afford the copay.   This case was linked to MOD-2021-299891 (Patient Link).